Agios Pharmaceuticals

AGIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.088 B

$34.97 +3.00%

Close of 22 Sept 2026

Revenue

$54.0M

#2704 by revenue

Earnings

-$413.0M

Loss-making

Shares outstanding

59,701,882

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#106Braveheart BioBRVE$2.13B
#107UroGen PharmaURGN$2.09B
#108Agios PharmaceuticalsAGIO$2.09B
#109Nektar TherapeuticsNKTR$2.08B
#110COMPASS PathwaysCMPS$2.05B

What if Agios Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$506,415.69

Per share 14,481× higher

Bitcoin $1.74T

$29,172.53

Per share 834× higher

Nvidia $5.52T

$92,388.49

Per share 2,642× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Agios Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.